Renaissance Technologies’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,546
Closed -$380K 4659
2022
Q1
$380K Sell
31,546
-35,905
-53% -$433K ﹤0.01% 3359
2021
Q4
$695K Buy
67,451
+36,833
+120% +$380K ﹤0.01% 2915
2021
Q3
$992K Sell
30,618
-3,138
-9% -$102K ﹤0.01% 2555
2021
Q2
$1.45M Buy
33,756
+9,833
+41% +$421K ﹤0.01% 2461
2021
Q1
$1.17M Buy
23,923
+4,412
+23% +$216K ﹤0.01% 2542
2020
Q4
$685K Buy
19,511
+5,774
+42% +$203K ﹤0.01% 2687
2020
Q3
$558K Buy
13,737
+2,959
+27% +$120K ﹤0.01% 2773
2020
Q2
$485K Buy
10,778
+2,691
+33% +$121K ﹤0.01% 2894
2020
Q1
$433K Buy
8,087
+1,546
+24% +$82.8K ﹤0.01% 2831
2019
Q4
$442K Buy
6,541
+649
+11% +$43.9K ﹤0.01% 2948
2019
Q3
$1.11M Buy
5,892
+947
+19% +$178K ﹤0.01% 2555
2019
Q2
$1.32M Sell
4,945
-129
-3% -$34.5K ﹤0.01% 2561
2019
Q1
$1.92M Buy
5,074
+1,791
+55% +$677K ﹤0.01% 2322
2018
Q4
$1.22M Buy
3,283
+215
+7% +$79.9K ﹤0.01% 2480
2018
Q3
$1.32M Buy
3,068
+282
+10% +$122K ﹤0.01% 2490
2018
Q2
$1.01M Buy
2,786
+340
+14% +$123K ﹤0.01% 2595
2018
Q1
$1.12M Buy
2,446
+296
+14% +$135K ﹤0.01% 2615
2017
Q4
$1.24M Buy
2,150
+316
+17% +$182K ﹤0.01% 2584
2017
Q3
$1.39M Buy
1,834
+316
+21% +$239K ﹤0.01% 2456
2017
Q2
$1.27M Buy
1,518
+197
+15% +$165K ﹤0.01% 2482
2017
Q1
$932K Buy
1,321
+75
+6% +$52.9K ﹤0.01% 2566
2016
Q4
$903K Buy
1,246
+113
+10% +$81.9K ﹤0.01% 2583
2016
Q3
$1.09M Buy
1,133
+206
+22% +$197K ﹤0.01% 2527
2016
Q2
$1.32M Buy
927
+269
+41% +$384K ﹤0.01% 2418
2016
Q1
$811K Buy
658
+151
+30% +$186K ﹤0.01% 2676
2015
Q4
$655K Buy
507
+136
+37% +$176K ﹤0.01% 2636
2015
Q3
$538K Buy
371
+7
+2% +$10.2K ﹤0.01% 2601
2015
Q2
$803K Buy
364
+89
+32% +$196K ﹤0.01% 2555
2015
Q1
$819K Buy
275
+183
+199% +$545K ﹤0.01% 2405
2014
Q4
$303K Buy
+92
New +$303K ﹤0.01% 2580
2014
Q1
Sell
-107
Closed -$399K 3063
2013
Q4
$399K Buy
107
+40
+60% +$149K ﹤0.01% 2421
2013
Q3
$265K Buy
+67
New +$265K ﹤0.01% 2501